Combined treatments against SARS-CoV-2 are emerging and some have taken into account the post-COVID-19 fibrosis. The aim of this survey was to report the experience of treating COVID-19 patients with pirfenidone, nitazoxanide (NTZ) and colchicine. It was a case series report of COVID-19 patients treated from December 2020 to March 2021, in a rural health center located in the State of Mexico, Mexico. 23 patients were included (mean age 44.5 ± 17.1 years), 12 women (mean age 45.9 ± 17.9 years) and 11 men (mean age 43 ± 16.9 years) with four deaths (17.39%). The evolution time was of 17.3 ± 6.7 days being the main symptoms fever (82.6%), myalgia (69.6%) and cough (65.2%). The main comorbidities were overweight/obesity 18 (78.26%), type 2 diab...
ObjectivesEffective treatments for coronavirus disease 2019 (COVID-19) are urgently needed. We hypot...
BackgroundDue to the wide spread of SARS-CoV2 around the world, the risk of death in individuals wit...
Introduction: coronavirus pandemic has led to 1.8 million deaths worldwide as of May 1st, 2021. Nita...
Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low, mild to ...
SARS-CoV-2 leads to an inflammatory and fibrotic state in the lungs which can be the cause of death ...
to describe the results of treating COVID-19 positive patients with nitazoxanide in three clinical s...
The use of nitazoxanide has previously yielded successful results in vitro against the coronavirus. ...
Abstract Background To date, there is no specific antiviral therapy for severe acute respiratory syn...
ObjectiveThere is an urgent need for effective treatments to prevent or attenuate lung and systemic ...
BackgroundThe 2020 pandemic of SARS-CoV-2 causing COVID-19 disease is an unprecedented global emerge...
Abstract Background The 2020 pandemic of SARS-CoV-2 causing COVID-19 disease is an unprecedented glo...
The impact of COVID-19 prompted a race to find a treatment that would reduce its mortality. Most stu...
Background Colchicine has been proposed as a treatment for COVID-19 on the basis of its anti-i...
Data from several cohorts of coronavirus disease 2019 (COVID-19) suggest that the most common comorb...
Objective: To evaluate whether the addition of colchicine to standard of care (SOC) results in bette...
ObjectivesEffective treatments for coronavirus disease 2019 (COVID-19) are urgently needed. We hypot...
BackgroundDue to the wide spread of SARS-CoV2 around the world, the risk of death in individuals wit...
Introduction: coronavirus pandemic has led to 1.8 million deaths worldwide as of May 1st, 2021. Nita...
Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low, mild to ...
SARS-CoV-2 leads to an inflammatory and fibrotic state in the lungs which can be the cause of death ...
to describe the results of treating COVID-19 positive patients with nitazoxanide in three clinical s...
The use of nitazoxanide has previously yielded successful results in vitro against the coronavirus. ...
Abstract Background To date, there is no specific antiviral therapy for severe acute respiratory syn...
ObjectiveThere is an urgent need for effective treatments to prevent or attenuate lung and systemic ...
BackgroundThe 2020 pandemic of SARS-CoV-2 causing COVID-19 disease is an unprecedented global emerge...
Abstract Background The 2020 pandemic of SARS-CoV-2 causing COVID-19 disease is an unprecedented glo...
The impact of COVID-19 prompted a race to find a treatment that would reduce its mortality. Most stu...
Background Colchicine has been proposed as a treatment for COVID-19 on the basis of its anti-i...
Data from several cohorts of coronavirus disease 2019 (COVID-19) suggest that the most common comorb...
Objective: To evaluate whether the addition of colchicine to standard of care (SOC) results in bette...
ObjectivesEffective treatments for coronavirus disease 2019 (COVID-19) are urgently needed. We hypot...
BackgroundDue to the wide spread of SARS-CoV2 around the world, the risk of death in individuals wit...
Introduction: coronavirus pandemic has led to 1.8 million deaths worldwide as of May 1st, 2021. Nita...